Levocetirizine Dihydrochloride 5 Mg Film-Coated Tablets
Levocetirizine dihydrochloride 5 mg film-coated tablets
Each film-coated tablet contains 5 mg levocetirizine dihydrochloride
Contains lactose: see leaflet for further information
film-coated tablet
7 film-coated tablets 10 film-coated tablets
14 film-coated tablets
15 film-coated tablets
20 film-coated tablets
21 film-coated tablets 28 film-coated tablets 30 film-coated tablets 40 film-coated tablets 50 film-coated tablets 56 film-coated tablets 60 film-coated tablets 70 film-coated tablets 90 film-coated tablets 100 film-coated tablets 112 film-coated tablets 120 film-coated tablets
Read the package leaflet before use. Oral use.
6. SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN
Keep out of the sight and reach of children.
7. OTHER SPECIAL WARNING(S), IF NECESSARY
8. EXPIRY DATE
EXP.: {mm/yyyy}
9. SPECIAL STORAGE CONDITIONS
Store in the original package to protect from moisture
10. SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE
11. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER
Ratiopharm GmbH, Graf-Arco-Strasse 3, 89079 Ulm, Germany.
12. MARKETING AUTHORISATION NUMBER(S)
PL 15773/0862
13. BATCH NUMBER
Batch No.:
14. GENERAL CLASSIFICATION FOR SUPPLY
POM
15. INSTRUCTIONS ON USE
Use as directed by your doctor.
16. INFORMATION IN BRAILLE
Levocetirizine dihydrochloride 5 mg tablets
17. UNIQUE IDENTIFIER - 2D BARCODE
<2D barcode carrying the unique identifier included.>
18. UNIQUE IDENTIFIER - HUMAN READABLE DATA
PC:
SN:
NN:
MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS PVC/PVDC:Al Blister / oPA/Al:PVC:Al Blister_
1. NAME OF THE MEDICINAL PRODUCT
Levocetirizine dihydrochloride 5 mg tablets
2. NAME OF THE MARKETING AUTHORISATION HOLDER
Ratiopharm GmbH
3. EXPIRY DATE
EXP.: {mm/yyyy}
4. BATCH NUMBER
Batch No.:
5 OTHER
REG0080101 Version 1.0 Effective Page 1 of 2